Thymol Nanoemulsion: A New Therapeutic Option for Extensively Drug Resistant Foodborne Pathogens.
Thymol Nanoemulsion: A New Therapeutic Option for Extensively Drug Resistant Foodborne Pathogens.
复制标题
DOI:
10.3390/antibiotics10010025
复制
发表时间:
2020-12-30
期刊:
影响因子:
--
通讯作者:
Abd El-Hamid MI
中科院分区:
文献类型:
--
作者:
Bendary MM;Ibrahim D;Mosbah RA;Mosallam F;Hegazy WAH;Awad NFS;Alshareef WA;Alomar SY;Zaitone SA;Abd El-Hamid MI
Foodborne pathogens have been associated with severe and complicated diseases. Therefore, these types of infections are a concern for public health officials and food and dairy industries. Regarding the wide-spread multidrug resistant (MDR) and extensively drug resistant (XDR) foodborne pathogens such as Salmonella Enteritidis (S. Enteritidis), new and alternative therapeutic approaches are urgently needed. Therefore, we investigated the antimicrobial, anti-virulence, and immunostimulant activities of a stable formulation of thymol as thymol nanoemulsion in an in vivo approach. Notably, treatment with 2.25% thymol nanoemulsion led to a pronounced improvement in the body weight gain and feed conversion ratio in addition to decreases in the severity of clinical findings and mortality percentages of challenged chickens with XDR S. Enteritidis confirming its pronounced antimicrobial activities. Moreover, thymol nanoemulsion, at this dose, had protective effects through up-regulation of the protective cytokines and down-regulation of XDR S. Enteritidis sopB virulence gene and interleukins (IL)-4 and IL-10 cytokines as those hinder the host defenses. Furthermore, it enhanced the growth of gut Bifidobacteria species, which increases the strength of the immune system. For that, we suggested the therapeutic use of thymol nanoemulsion against resistant foodborne pathogens. Finally, we recommended the use of 2.25% thymol nanoemulsion as a feed additive for immunocompromised individuals as well as in the veterinary fields.
登录
查看更多内容
DOI:
10.1155/2014/651593
发表时间:
2014
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Bilia AR;Guccione C;Isacchi B;Righeschi C;Firenzuoli F;Bergonzi MC
通讯作者:
Bergonzi MC
DOI:
10.3390/antibiotics9100667
发表时间:
2020-10-03
期刊:
Antibiotics (Basel, Switzerland)
影响因子:
--
作者:
Abd El-Hamid MI;Y El-Naenaeey ES;M Kandeel T;Hegazy WAH;Mosbah RA;Nassar MS;Bakhrebah MA;Abdulaal WH;Alhakamy NA;Bendary MM
通讯作者:
Bendary MM
影响因子:
5.2
作者:
Abd El-Hamid, Marwa, I;Abd El-Aziz, Norhan K.;Bendary, Mahmoud M.
通讯作者:
Bendary, Mahmoud M.
DOI:
10.1111/j.1365-2672.1994.tb03443.x
发表时间:
1994-10-01
期刊:
JOURNAL OF APPLIED BACTERIOLOGY
影响因子:
--
作者:
GIBSON, GR;WANG, X
通讯作者:
WANG, X
影响因子:
4
作者:
Awad, N. F. S.;Abd El-Hamid, M. I.;Mahmoud, H. I.
通讯作者:
Mahmoud, H. I.